Citations

Clear

13603 citation(s) found for "_, _".

Antiamyloid Monoclonal Antibodies in Alzheimer’s Disease, Part 2: Challenges in Dementia Care Delivery System Logistics
Carlisle, Tara C. , Bateman, James R. , Yang, Yanghong , Lachner, Christian, Stockbridge, Melissa D. , Flashman, Laura A. , Chemali, Zeina , Alzbeidi, Nasir, Pressman, Peter , Osibajo, Anne-Marie, Bobrin, Bradford D., Martinez-Menendez, Carlos J., Teixeira, Antonio L., Daffner, Kirk R. , Pressman, Peter S, Stockbridge, Melissa D , Lachner, Christian , Bobrin, Bradford D., Teixeira, Antônio Lúcio

Mayo Clinic

The Journal of Neuropsychiatry and Clinical Neurosciences | June 26, 2025 | Volume: 37 | Issue: 4 | Pages: 378-384

10.1176/appi.neuropsych.20240203 | PMID 40566858 Get It

C-Type Natriuretic Peptide: Protecting the Aorta
Sangaralingham, S. Jeson , Burnett, John C. , Sangaralingham, S. Jeson

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | June 25, 2025 | Volume: 45 | Issue: 7 | Pages: 1064-1066

10.1161/atvbaha.125.322802 | PMID 40560989 Get It

Differences in Orthopaedic Surgeon Merit-based Incentive Payment System (MIPS) Performance, Demographics, and Patient Populations Based on Patient Social Risk
Holle, Alejandro M. , Lin, Eugenia , Gill, Vikram S. , Haglin, Jack M. , Clarke, Henry D. , Holle, Alejandro

Mayo Clinic

Journal of Bone and Joint Surgery | June 25, 2025 | Volume: 107 | Issue: 15 | Pages: 1726-1735

10.2106/jbjs.24.01419 | PMID 40560965 Get It

Background: The Centers for Medicare & Medicaid Services (CMS) Merit-based Incentive Payment System (MIPS) has undergone numerous changes to promote care for patients at high social risk. However, the effect of these changes on surgeon MIPS performance and caseload selection remains unclear. Thus, the purpose of this study was to evaluate how orthopaedic surgeon MIPS scores, demographics, practice characteristics, and patient populations varied on the basis of patient social risk in 2017 compared with 2021. Methods: CMS data were utilized to examine U.S. orthopaedic surgeons. Surgeons were placed into social-risk quintiles on the basis of the proportion of their patients who were dually eligible for Medicare and Medicaid, with the highest quintile representing the highest social risk. Demographics, practice location characteristics, patient data, and MIPS performance were assessed for the years 2017 and 2021. Differences between social-risk quintiles were assessed utilizing chi-square, Student t, and Wilcoxon signed-rank tests and multivariable logistic regression. Results: In 2017, surgeons with caseloads at the highest, compared with the lowest, social risk had lower MIPS performance scores (mean [and standard deviation], 66.0 ± 37.6 versus 70.1 ± 33.5; p < 0.001). However, in 2021, orthopaedic surgeons with caseloads at the highest, compared with the lowest, social risk had significantly higher MIPS performance scores (mean, 88.7 ± 16.9 versus 81.5 ± 18.3; p < 0.001). In terms of demographics, in 2021, orthopaedic surgeons with caseloads at the highest, compared with the lowest, social risk were more often women (9.2% versus 3.6%; p < 0.001), more often had a DO degree (11.2% versus 6.6%; p < 0.001), more recently graduated from medical school (mean, 23.0 ± 12.9 versus 25.7 ± 10.9 years; p < 0.001), and worked in areas with higher Distressed Communities Index (DCI) distress scores (mean, 56.9 ± 27.3 versus 35.1 ± 25.2; p < 0.001). Similar findings were present in 2017. Conclusions: The addition of the Complex Patient Bonus to the MIPS in 2020 may have reduced performance inequities in MIPS scoring for surgeons with caseloads at high social risk. However, the demographics and practice patterns of the orthopaedic surgeons caring for populations at the highest social risk remained consistent between years. Level of Evidence: Prognostic Level III . See Instructions for Authors for a complete description of levels of evidence.
Congenital Glottic Web in Young Active-Duty Female
Shirke, Neeti , Rutt, Amy L. , Rutt, Amy L.

Mayo Clinic

Ear, Nose & Throat Journal | June 25, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/01455613251351784 | PMID 40560662 Get It

Phase I First-in-Human Study of TRK-950, an IgG1 Antibody Specific to CAPRIN-1, in Patients with Advanced Solid Tumors
Cassier, Philippe A. , Borad, Mitesh J. , Sharma, Sunil , Dubois, Bertrand , Caux, Christophe , Okano, Fumiyoshi , Hoff, Daniel D. Von , Blay, Jean‐Yves , Von Hoff, Daniel D , Blay, Jean-Yves , Borad, Mitesh J

Mayo Clinic

Cancer Research Communications | June 25, 2025 | Volume: 5 | Issue: 7 | Pages: 1119-1128

10.1158/2767-9764.crc-25-0123 | PMID 40557916 Get It

Abstract Purpose: TRK-950 is a first-in-class humanized antibody targeting cytoplasmic activation/proliferation-associated protein-1, which is strongly expressed on the cell membrane surface in or on most solid tumors but not in or on normal tissues. This first-in-human study investigated the safety profile, pharmacokinetics (PK), and preliminary antitumor activity. Patients and Methods: Patients with treatment-refractory, locally advanced, or metastatic solid tumors were enrolled in a dose escalation/expansion study. TRK-950 was administered intravenously weekly for 3 weeks in a 28-day cycle, with doses ranging from 3 to 30 mg/kg. Dose expansion included 10 mg/kg weekly and 30 mg/kg biweekly for colorectal cancer and 10 mg/kg weekly for cholangiocarcinoma. The primary objective of this study was to determine its safety, tolerability, and maximum tolerated dose. The secondary objectives were PK, preliminary antitumor activity, and identification of potential biomarkers. Results: Thirty-six patients received at least one dose of TRK-950. In the dose escalation cohort, the maximum tolerated dose was not reached, and no dose-limiting toxicities were observed up to 30 mg/kg. Common adverse events included abdominal pain, fatigue, constipation, back pain, nausea, and decreased appetite. TRK-950 exhibited a PK profile similar to that of other IgG subclass 1 therapeutic antibodies, with linear PK parameters over the 3 to 30 mg/kg dose range. The best response was stable disease. Notably, one patient with cholangiocarcinoma showed signs of cavitation after approximately 8 months, suggesting potential antitumor activity. Conclusions: TRK-950 is safe and well tolerated, has a favorable PK profile, and should be further investigated as a monotherapy and in combination with standard treatment for various types of solid tumors. Significance: TRK-950, a humanized antibody targeting CAPRIN-1, demonstrated good tolerability, no dose-limiting toxicities, a favorable PK profile, and potential antitumor activity in this first-in-human study. Currently, TRK-950 is undergoing Phase Ib and II trials for various cancers, showing promising development potential.
Tea and Tablets: What I Learned About Healing in Chupuro, Peru
Badell, Camila S. , Ponce, Oscar J. , Ruíz, Eloy , Ponce, Oscar Josue , Ruiz, Eloy F , Badell, Camila Sofía

Mayo Clinic

Journal of the American Geriatrics Society | June 25, 2025 | Volume: 73 | Issue: 10 | Pages: 3259-3260

10.1111/jgs.19597 | PMID 40557593 Get It

Clinical, Serologic, and Histopathologic Features of Patients With Pemphigus With Either Positive or Negative IgG4 Intercellular Deposition by Direct Immunofluorescence (DIF): A Retrospective Case–Control Study of 55 DIF Bi
Garbanzos, Clint Christian T. , Hardway, Heather D , Lehman, Julia S. , Lehman, Julia S , Todd, Austin W. , Hardway, Heather

Mayo Clinic

Journal of Cutaneous Pathology | June 24, 2025 | Volume: 52 | Issue: 9 | Pages: 580-589

10.1111/cup.14835 | PMID 40555471 Get It

ABSTRACTBackgroundIntercellular IgG4 deposition is variably present on DIF in patients with pemphigus. Whether this feature has clinical, serologic, or histopathologic correlates was unknown.MethodsWe identified 34 patients with pemphigus who had 55 DIF specimens reported to show intercellular IgG, IgG4, and/or C3 deposition (8/22/2017–11/30/2023). Patients and biopsies were stratified by intercellular IgG4 status. Clinical and serologic data were extracted from electronic records, and corresponding biopsy slides were reviewed for histopathologic findings.ResultsAmong the 34 patients with pemphigus, patients with positive IgG4 were significantly more likely to have detectable serum anti‐desmoglein 1/3 antibodies by ELISA (p = 0.014 and p = 0.030, respectively). Paraneoplastic pemphigus (PNP) was more frequent in the IgG4‐negative group (p = 0.037), particularly among patients with ocular involvement. Of 55 DIF biopsy specimens meeting inclusion criteria, 52 (94.5%) had intercellular IgG deposition and 42 (76.4%) had intercellular IgG4 on DIF. Compared to IgG4‐negative specimens, IgG4‐positive specimens were significantly more likely to represent a vesiculobullous lesion (p = 0.024), to be derived from the trunk (p = 0.047), to show histologic acantholysis (p = 0.019) and to lack lichenoid inflammation (p = 0.0004).ConclusionFor pemphigus, DIF IgG4 status correlated with ocular involvement, the clinical morphology selected for biopsy, the likelihood of detecting circulating desmoglein antibodies, the presence of specific histopathologic features such as acantholysis and lichenoid inflammation, and the likelihood of having a final diagnosis of PNP. Further studies are needed to determine whether the presence of tissue‐bound intercellular IgG4 antibodies correlates with particular disease variants or lesion‐specific characteristics.
New Diagnosis of Granulomatosis With Polyangiitis Presenting With Oral Ulcerations, Ileitis, and Hematochezia
Rolak, Stacey , Pham, Michael M., Lam‐Himlin, Dora , Batheja, Mashal, Lam-Himlin, Dora M, Batheja, Mashal J, Pham, Michael M.

Mayo Clinic

ACG Case Reports Journal | June 24, 2025 | Volume: 12 | Issue: 6 | Pages: e01746

10.14309/crj.0000000000001746 | PMID 40567528 Get It

ABSTRACT Granulomatosis with polyangiitis (GPA) is a rare small vessel vasculitis that commonly presents with multiorgan involvement of the upper airways, lungs, and kidneys. We report a 55 year-old-man who presented with painful oral ulcers, diffuse joint pain, epistaxis, and intermittent maroon bowel movements. Infectious evaluation was unremarkable. Rheumatologic evaluation demonstrated elevated c-anti-neutrophil cytoplasmic antibody and proteinase 3 antibodies. Colonoscopy with terminal ileum biopsies demonstrated angiocentric inflammatory findings supportive of a diagnosis of GPA. This case was unusual in its presentation with predominately oral manifestations. A diagnosis of GPA should remain on the differential for patients with gastrointestinal bleeding, and these systemic symptoms require a high level of suspicion to lead to timely diagnosis.
Comparing FIB-4, VCTE, pSWE, 2D-SWE, and MRE Thresholds and Diagnostic Accuracies for Detecting Hepatic Fibrosis in Patients with MASLD: A Systematic Review and Meta-Analysis
Wilson, Mitchell P. , Singh, Ranjit , Mehta, Shyam B. , Fung, Christopher , Low, Gavin , Wilson, Mitchell Patrick , Murad, Mohammad Hassan, Fung, Christopher , Low, Gavin , Mehta, Shyam, Murad, M. Hassan

Mayo Clinic

Diagnostics | June 24, 2025 | Volume: 15 | Issue: 13 | Pages: 1598

10.3390/diagnostics15131598 | PMID 40647597 Get It

Objectives: To compare thresholds and accuracies of FIB-4, vibration-controlled transient elastography (VCTE), point shear wave elastography (pSWE), 2D shear wave elastography (2D-SWE), and MR elastography (MRE) for detecting hepatic fibrosis in patients with MASLD. Materials and Methods: Systematic searching of MEDLINE, EMBASE, Cochrane Library, Scopus, and the gray literature from inception to March 2024 was performed. Studies evaluating accuracies of FIB-4, VCTE, 2D-SWE, pSWE, and/or MRE for detecting significant (≥F2) and/or advanced (≥F3) hepatic fibrosis in MASLD patients compared to histology were identified. Full-text review and data extraction were performed independently by two reviewers. Multivariate meta-analysis and subgroup analyses were performed using index test and fibrosis grading. Risk of bias was assessed using QUADAS-2. Results: 207 studies with over 80,000 patient investigations were included. FIB-4 1.3 threshold sensitivity was 71% (95% CI 66–75%) for detecting advanced hepatic fibrosis, which improved to 88% (85–91%) using a <0.75 threshold. FIB-4 specificity using a 2.67 threshold was 96% (94–97%). Sensitivities of 88–91% were achieved using thresholds of 3.2 kPa for pSWE, 4.92 kPa for 2D-SWE, 7.18 kPa for VCTE, and 2.32 kPa for MRE. No significant differences were identified for sensitivities in subgroup analysis with thresholds between 7 and 9 kPa. Most imaging-based studies were high risk of bias for the index test. Conclusions: A FIB-4 threshold of <0.75 and modality-dependent thresholds (VCTE < 7 kPa; pSWE <3 kPa; 2D-SWE <5 kPa; and MRE <2.5 kPa) would achieve sensitivities of around 90% when defining low-risk MASLD in population screening. A modified two-tier algorithm aligning with existing Society of Radiologists in Ultrasound guidelines would improve risk stratification accuracies compared to existing guidelines by European and American liver societies.
RAGE Inhibition Reduces Allergen-Induced ATP Release, Ca 2+ Mobilization and Type 2 Immunity In Airways
Srisomboon, Yotsawee, Iijima, Koji, Iijima, Koji, Kita, Hirohito , O’Grady, Scott M.

Mayo Clinic

Physiology | June 23, 2025 | Volume: 40 | Issue: S1 | Pages: No page available

10.1152/physiol.2025.40.s1.0568 Get It

Allergens from the fungus Alternaria alternata promote secretion of alarmins from the airway epithelium including ATP, IL-33 and both genomic and mitochondrial DNA fragments, which produce type 2 immune responses in airways. Alternaria -induced oxidative stress activates ATP release by opening apical voltage-dependent anion channels (VDAC-1) and stimulating exocytosis of ATP. This investigation demonstrated that treatment of human bronchial epithelial (hBE) cells with a selective peptide antagonist or small molecule inhibitor (FPS-ZM 1 ) of the receptor for advanced glycation end products (RAGE), reduced Alternaria -evoked ATP secretion, decreasing the initial rate by ~40%. Furthermore, the Alternaria -induced increase in intracellular Ca 2+ concentration ([Ca 2+ ] i ) was inhibited by ~75% following pretreatment with RAGE antagonist peptide. Intranasal administration of Alternaria extract (50 μg) produced a significant increase in IL-33 secretion into bronchoalveolar lavage (BAL) fluid, which was inhibited in RAGE-deficient ( Ager -/- ) mice. Moreover, Alternaria -induced increases in IL-5 and IL-13 secretion into BAL fluid were also significantly reduced in Ager -/- mice. These findings support the conclusion that Alternaria -dependent ATP release and Ca 2+ mobilization was dependent in part on RAGE activation and that RAGE antagonists have the potential of reducing type 2 immune responses in airways following Alternaria allergen exposure. This study was supported by grants from the NIH (R01A1128729 & 1R01AI169530) to HK and SMO and by the Minnesota Agricultural Experiment station grant (AES0016134) to SMO. This abstract was presented at the American Physiology Summit 2025 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.